Vaccination News Home Page                                            subscribe Vaccination NewsLetter

http://www.sciencedirect.com/science?_ob=IssueURL&_tockey=%23TOC%235188%232003%23999789990%23380116%23FLA%23Volume_21,_Issues_9-10,_Pages_827-1032_(14_February_2003)&_auth=y&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=f706f32a4ffde41c452c8e92b3796146

Go to ScienceDirect Home Skip Main Navigation Links
 Register or Login:   Password:     Athens Login 
HomeBrowse JournalsBrowse Abstract DatabasesBrowse Reference WorksMy AlertsMy Profile Help (Opens new window)
Issues
Vaccine
Copyright © 2003 Elsevier Science Ltd. All rights reserved

Volume 21, Issues 9-10,
Pages 827-1032 (14 February 2003)
   
E-mail Articles
        Selected checked docs: display checked docs
1.
Immunopotentiatiors in modern vaccines, Page 827
Virgil E. J. C. Schijns
Abstract | Full Text + Links | PDF (16 K)
2.
Mechanisms of vaccine adjuvant activity: initiation and regulation of immune responses by vaccine adjuvants, Pages 829-831
Virgil E. J. C. Schijns
Abstract | Full Text + Links | PDF (40 K)
3.
Recombinant congenic strains of mice: a new tool for the genetic dissection of efficacy and toxicity of adjuvants, Pages 832-835
Sergio Di Marco, Jacques Moisan, Marie-Linda Boghdady, Emil Skamene and Danuta Radzioch
Abstract | Full Text + Links | PDF (58 K)
4.
The adjuvant OM-174 induces both the migration and maturation of murine dendritic cells in vivo, Pages 836-842
Bernard Pajak, Virginie Garze, Gwyn Davies, Jacques Bauer, Muriel Moser and Carlo Chiavaroli
Abstract | Full Text + Links | PDF (828 K)
5.
Low effectiveness of DNA vaccination against HER-2/neu in ageing, Pages 843-848
Mauro Provinciali, Arianna Smorlesi, Alessia Donnini, Beatrice Bartozzi and Augusto Amici
Abstract | Full Text + Links | PDF (118 K)
6.
Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro, Pages 849-855
Hongfan Sun, Kevin G. J. Pollock and James M. Brewer
Abstract | Full Text + Links | PDF (258 K)
7.
Maturation of human dendritic cells induced by the adjuvant cholera toxin: role of cAMP on chemokine receptor expression, Pages 856-861
Maria Cristina Gagliardi and Maria Teresa De Magistris
Abstract | Full Text + Links | PDF (169 K)
8.
MHC class II engagement by its ligand LAG-3 (CD223) leads to a distinct pattern of chemokine and chemokine receptor expression by human dendritic cells, Pages 862-868
Sandrine Buisson and Frédéric Triebel
Abstract | Full Text + Links | PDF (236 K)
9.
Dendritic cell KLH loading requirements for efficient CD4+ T-cell priming and help to peptide-specific cytotoxic T-cell response, in view of potential use in cancer vaccines, Pages 869-876
A. L. Millard, D. Ittelet, F. Schooneman and J. Bernard
Abstract | Full Text + Links | PDF (201 K)
10.
Generation of antigen-loaded dendritic cells in a serum-free medium using different cytokine combinations, Pages 877-882
Tomas Büchler, Roman Hajek, Lida Bourkova, Lucie Kovarova, Romana Musilova, Alena Bulikova, Michal Doubek, Adam Svobodnik, Iveta Mareschova, Pavlina Vanova et al.
Abstract | Full Text + Links | PDF (71 K)
11.
Liposomal delivery of antigen to human dendritic cells, Pages 883-890
Melissa J. Copland, Margaret A. Baird, Thomas Rades, Judith L. McKenzie, Bernd Becker, Folkert Reck, Peter C. Tyler and Nigel M. Davies
Abstract | Full Text + Links | PDF (217 K)
12.
Interleukin-2 and dendritic cells as adjuvants for surgical therapy of tumours associated with human papillomavirus type 16, Pages 891-896
Jan Bubeník, Romana MikyImageková, Vladimír Vonka, Luis Mendoza, Jana Imageímová, Michal Imagemahel and Marie Indrová
Abstract | Full Text + Links | PDF (93 K)
13.
Immunopotentiating heat shock proteins: negotiators between innate danger and control of autoimmunity, Pages 897-901
Willem van Eden, Ad Koets, Peter van Kooten, Berent Prakken and Ruurd van der Zee
Abstract | Full Text + Links | PDF (144 K)
14.
Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins, Pages 902-914
Judy A. Mitchell, Thomas D. Green, Rick A. Bright and Ted M. Ross
Abstract | Full Text + Links | PDF (323 K)
15.
Liposomes and ISCOMs, Pages 915-920
Gideon F. A. Kersten and Daan J. A. Crommelin
Abstract | Full Text + Links | PDF (242 K)
16.
Immunostimulating reconstituted influenza virosomes, Pages 921-924
Rinaldo Zurbriggen
Abstract | Full Text + Links | PDF (164 K)
17.
Influenza virosomes: combining optimal presentation of hemagglutinin with immunopotentiating activity, Pages 925-931
Anke Huckriede, Laura Bungener, Wouter ter Veer, Marijke Holtrop, Toos Daemen, Abraham M. Palache and Jan Wilschut
Abstract | Full Text + Links | PDF (175 K)
18.
Influenza hemagglutinin peptides fused to interferon gamma and encapsulated in liposomes protects mice against influenza infection, Pages 932-939
L. Faulkner, G. Buchan, L. Slobbe, E. Lockhart, J. Wales, M. Wilson and M. Baird
Abstract | Full Text + Links | PDF (149 K)
19.
Effect of priming on subsequent response to inactivated influenza vaccine, Pages 940-945
C. W. Potter and R. Jennings
Abstract | Full Text + Links | PDF (143 K)
20.
Intranasal vaccination with ISCOMATRIX® adjuvanted influenza vaccine, Pages 946-949
Alan Coulter, Rodney Harris, Roslyn Davis, Debbie Drane, John Cox, David Ryan, Phil Sutton, Steve Rockman and Martin Pearse
Abstract | Full Text + Links | PDF (123 K)
21.
Restored functional immunogenicity of purified meningococcal PorA by incorporation into liposomes, Pages 950-960
Carmen Arigita, Gideon F. A. Kersten, Ton Hazendonk, Wim E. Hennink, Daan J. A. Crommelin and Wim Jiskoot
Abstract | Full Text + Links | PDF (193 K)
22.
Novel synthetic LPS receptor agonists boost systemic and mucosal antibody responses in mice, Pages 961-970
Melinda Przetak, Jesse Chow, Hongsheng Cheng, Jeffrey Rose, Lynn D. Hawkins and Sally T. Ishizaka
Abstract | Full Text + Links | PDF (295 K)
23.
Adjuvant activity of peptidoglycan monomer and its metabolic products, Pages 971-976
Beata Halassy, Marina KrstanoviImage, RuImagea Frkanec and Jelka TomaImageiImage
Abstract | Full Text + Links | PDF (97 K)
24.
Evaluation of adjuvants for protein vaccines against tuberculosis in guinea pigs, Pages 977-982
Philip J. Hogarth, Keith J. Jahans, Rolf Hecker, R. Glyn Hewinson and Mark A. Chambers
Abstract | Full Text + Links | PDF (119 K)
25.
Development of short non-CpG phosphodiester oligonucleotides as immune stimulatory agents, Pages 983-989
Mario C. Filion, Nathalie Saha, Mohamed Gueddi and Nigel C. Phillips
Abstract | Full Text + Links | PDF (239 K)
26.
Immunostimulatory DNA as adjuvant: efficacy of phosphodiester CpG oligonucleotides is enhanced by 3' sequence modifications, Pages 990-995
Stefan Zimmermann, Klaus Heeg and Alexander Dalpke
Abstract | Full Text + Links | PDF (128 K)
27.
A non-toxic lectin for antigen delivery of plant-based mucosal vaccines, Pages 997-1005
Fabricio Medina-Bolivar, Rhonda Wright, Vanessa Funk, Danielle Sentz, Lisa Barroso, Tracy D. Wilkins, William Petri, Jr. and Carole L. Cramer
Abstract | Full Text + Links | PDF (254 K)
28.
Investigation of several selected adjuvants regarding their efficacy and side effects for the production of a vaccine for parakeets to prevent a disease caused by a paramyxovirus type 3, Pages 1006-1022
Ingrid Beck, Helga Gerlach, E. Burkhardt and E. F. Kaleta
Abstract | Full Text + Links | PDF (437 K)
29.
Reduced faecal excretion of F4+-E. coli by the intramuscular immunisation of suckling piglets by the addition of 1small alpha, Greek,25-dihydroxyvitamin D3 or CpG-oligodeoxynucleotides, Pages 1023-1032
Y. Van der Stede, E. Cox, F. Verdonck, S. Vancaeneghem and B. M. Goddeeris
Abstract | Full Text + Links | PDF (177 K)
30.
Editorial Board/Aims and Scope, Page CO2

PDF (42 K)


 

E-mail Articles
Issues
HomeBrowse JournalsBrowse Abstract DatabasesBrowse Reference WorksMy AlertsMy Profile   Help (Opens new window)


 

Send feedback to ScienceDirect
Software and compilation © 2003 ScienceDirect. All rights reserved.
ScienceDirect® is an Elsevier Science B.V. registered trademark.


Your use of this service is governed by Terms and Conditions. Please review our Privacy Policy for details on how we protect information that you supply.

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.